Markets Gone Wild

MustGrow Biologics Signs Exclusive Distribution Agreement with Adjuvants Plus: A Game-Changer in the AgTech Industry MustGrow Biologics Corp. (MGRO, MGROF) made waves in the Agtech industry this week with the announcement of a five-year exclusive distribution agreement with Adjuvants Plus. This strategic partnership will enable MustGrow to distribute Adjuvants’ product line across Canada through their…

Thermo Fisher Scientific Introduces Olink® Reveal for High-Plex Proteomics Setting a New Standard for Affordable Biomarker Identification UPPSALA, Sweden–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, has made a groundbreaking announcement today with the introduction of Olink® Reveal. This new technology sets a new standard for affordable, high-plex proteomics, allowing researchers to identify…

Recovering from Investment Losses: Regeneron Pharmaceuticals, Inc. Have you recently experienced a loss in your investment with Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)? If so, you may have the opportunity to seek recovery under the federal securities laws. It’s crucial to understand your rights as an investor and take action to protect your financial interests. Understanding Securities…

First Quantum Minerals Ltd. Reports Strong Financial Results for Q4 2024 Overview In United States dollars, First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) has reported net earnings attributable to shareholders of $99 million ($0.12 earnings per share) for the three months ended December 31, 2024 (“Q4 2024” or the “fourth quarter”)….

NurExone Biologic Inc. Receives Orphan Medicinal Product Designation for ExoPTEN Therapy TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) NurExone Biologic Inc. has recently announced that the European Medicines Agency has granted Orphan Medicinal Product Designation for the company’s ExoPTEN therapy. This is a significant milestone for NurExone, a biopharmaceutical company focused on developing…